Forward Pharma FA ApS: Financial statements 2021
CVR: 37281603
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Forward Pharma FA ApS (CVR 37281603) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -8,250 and a net result of DKK -11,447 compared with DKK -23,032 the year before. Equity in the 2021 report amounted to DKK 75,120. The solvency ratio was 11%.
- Gross Profit
- DKK -8,250
- Profit/Loss
- DKK -11,447
- Equity
- DKK 75,120
- Total Assets
- DKK 683,148
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -8 t. | -11 t. | 75 t. | - |
| 2020 | - | -19 t. | -23 t. | 87 t. | - |
| 2019 | - | -31 t. | -34 t. | 10 t. | - |
| 2018 | - | -25 t. | -28 t. | -56 t. | - |
| 2017 | - | -569 t. | -447 t. | -29 t. | - |
Official annual report
Find more companies like Forward Pharma FA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Forward Pharma FA ApS has published its annual report for 2020. Gross profit came to DKK -19,273, and the net result was DKK -23,032.
About Forward Pharma FA ApS
Forward Pharma FA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company has been dissolved on 27 October 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2022, the company reported a gross profit of DKK -32,125 and a net result of DKK -35,837 compared with DKK -11,447 the year before. Equity in the 2022 report amounted to DKK 39,283.